POY_1170x120_8-12-19

Peter Welch

Lawmakers call for TRICARE pilot extension

Lawmakers call for TRICARE pilot extension

ARLINGTON, Va. — Forty-nine members of Congress are urging House and Senate leaders to support a one-year extension of the TRICARE Acquisition Cost Parity Pilot Program for retail pharmacy. The National Association of Chain Drug Stores said late Wednesday that the bipartisan group of lawmakers — led by Reps. Buddy Carter (R., Ga.), Dave Loebsack

NCPA backs bill to boost preferred Rx network access

NCPA backs bill to boost preferred Rx network access

ALEXANDRIA, Va. — The National Community Pharmacists Association has endorsed legislation to foster pharmacy participation in preferred networks in Medicare Part D prescription drug plans. NCPA said the Ensuring Seniors Access to Local Pharmacies Act of 2017 (H.R. 1939), introduced by Reps. Morgan Griffith (R., Va.) and Peter Welch (D., Vt.), would enable pharmacies in

Congress reintroduces DIR fee legislation

Congress reintroduces DIR fee legislation

WASHINGTON — Reps. Morgan Griffith (R., Va.) and Peter Welch (D., Vt.) have reintroduced the Improving Transparency and Accuracy in Medicare Part D Spending Act (H.R. 1038), which community pharmacies say would squelch a growing burden: retroactive direct and indirect remuneration (DIR) fees. The bill, introduced Wednesday in the House of Representatives, would ban the application

Lawmakers marshal support for TRICARE pilot

Lawmakers marshal support for TRICARE pilot

ARLINGTON, Va. — A group of congressmen have called on House of Representatives and Senate leaders to advance a TRICARE pilot that would enable military veterans and families to opt to fill prescriptions at community pharmacies. The National Association of Chain Drug Stores said Wednesday that 37 House members have sent a letter to the

Senate report calls for higher generics usage

WASHINGTON — Providing incentives to prescription drug plan sponsors that increase generic drug use is among recommendations that the Senate Special Committee on Aging unveiled last month in a bipartisan report that focuses on ways to increase the utilization of generics within the Medicare Part D program. The panel also heard about industry issues beyond